12-05-2023, 08:34 AM
Definitely! Despite significant progress, there's still much we don't know on Egfr signaling pathways, resistance mechanisms, and optimal treatment method sequencing. Continued research and collaboration are essential to unraveling the full complication of Egfr-mutated lung cancer.